Cyclerion

Developer of therapies for treating sickle cell disease and diabetic nephropathy

placeCambridge, Massachusetts, United States calendar_todayFounded 2018 groups32 employees language cyclerion.com

Registered entities

Social engagement

Social engagement: 4.2K social following, 8 posts in the last 12 months — below the industry typical range.

Investor mix

8 investors on record.

Investor typeCountShare
Venture capital225%
Private equity225%
Other / undisclosed450%

Recent activity

5 Jan 2026
Partnership
Medsteer
10 Nov 2025
Event
Guggenheim Securities 2nd Annual Healthcare Innovation Conference
24 Sep 2025
Event
investor webcast
Coming soon